Overview

Pharmacodynamic Study of Cilostazol in Healthy Volunteers

Status:
Completed
Trial end date:
2018-03-30
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to investigate the effects of Cilostazol, Acetylsalycylic acid and Clopidogrel alone as well as combinations of Cilostazol/Acetylsalicylic acid and Cilostazol/ Clopidogrel on ex-vivo Platelet Function (PF) testing.
Phase:
Phase 1
Details
Lead Sponsor:
Otsuka Pharmaceutical Co., Ltd.
Treatments:
Aspirin
Cilostazol
Clopidogrel
Ticlopidine